RBM27 inhibitors belong to a specific class of chemical compounds designed to selectively modulate the activity of the RNA-binding motif protein 27 (RBM27). This protein is a member of the RNA-binding motif (RBM) family, characterized by its conserved RNA recognition motifs (RRMs) that enable interactions with RNA molecules. RBM27 is involved in post-transcriptional processes, participating in the regulation of mRNA splicing and stability. The inhibitors developed for RBM27 possess a tailored chemical structure that allows them to interact selectively with specific binding sites on the RBM27 protein, influencing its molecular activities within the cellular context. This precision in design is crucial for ensuring a high degree of specificity, minimizing unintended effects on other cellular components or RNA-binding proteins within the broader RBM family.
The mechanism of action of RBM27 inhibitors involves disrupting the normal functioning of the RBM27 protein, potentially impacting its role in mRNA processing and RNA-related pathways. As an RNA-binding protein, RBM27 contributes to the intricate network of cellular mechanisms governing gene expression and post-transcriptional regulation. The selectivity of these inhibitors is vital to prevent interference with other closely related RBM proteins or RNA-binding pathways. As researchers delve into the complexities of RNA metabolism and post-transcriptional control, RBM27 inhibitors serve as valuable tools, allowing for the investigation of the precise molecular mechanisms governed by RBM27. The study of this chemical class contributes to a deeper understanding of the role played by RBM27 in cellular physiology, offering insights into its potential functions within the complex networks that regulate mRNA dynamics and gene expression. Overall, the exploration of RBM27 inhibitors provides a platform for advancing our understanding of the molecular landscape surrounding RBM proteins and their involvement in post-transcriptional gene regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide is known to inhibit the transcription of various genes by affecting RNA polymerase II activity, potentially reducing RBM27 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin is a potent inhibitor of RNA polymerase II, which could lead to decreased transcription of RNA, including that of genes like RBM27. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA polymerase movement, which could reduce RBM27 mRNA synthesis. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases (CDKs) which are involved in the regulation of transcription and could therefore decrease RBM27 expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB is an adenosine analogue that inhibits RNA polymerase II and could thus reduce RBM27 mRNA levels. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Cordycepin is an adenosine analogue that can terminate mRNA elongation, potentially affecting the levels of RBM27 transcripts. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Rocaglates are a class of compounds that can inhibit translation initiation, potentially reducing the synthesis of the RBM27 protein. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits topoisomerase I, resulting in DNA damage and potentially disrupting the transcription of genes like RBM27. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Puromycin causes premature termination of protein synthesis, which can lead to reduced levels of proteins, including RBM27. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin interferes with peptide chain elongation during protein synthesis, potentially leading to decreased RBM27 protein levels. | ||||||